114 related articles for article (PubMed ID: 19528506)
1. A novel method to display [gal alpha1, 3 gal] antigens on human leukemic cells for preparation of anti-leukemia vaccines.
Posekany KJ; Wiley JE; Gagnon GA
Anticancer Res; 2009 Jun; 29(6):2387-92. PubMed ID: 19528506
[TBL] [Abstract][Full Text] [Related]
2. Anti-Gal-mediated targeting of human B lymphoma cells to antigen-presenting cells: a potential method for immunotherapy using autologous tumor cells.
Manches O; Plumas J; Lui G; Chaperot L; Molens JP; Sotto JJ; Bensa JC; Galili U
Haematologica; 2005 May; 90(5):625-34. PubMed ID: 15921377
[TBL] [Abstract][Full Text] [Related]
3. Human NK cells can lyse porcine endothelial cells independent of their expression of Galalpha(1,3)-Gal and killing is enhanced by activation of either effector or target cells.
Horvath-Arcidiacono JA; Porter CM; Bloom ET
Xenotransplantation; 2006 Jul; 13(4):318-27. PubMed ID: 16768725
[TBL] [Abstract][Full Text] [Related]
4. Allogeneic melanoma vaccine expressing alphaGal epitopes induces antitumor immunity to autologous antigens in mice without signs of toxicity.
Rossi GR; Mautino MR; Awwad DZ; Husske K; Lejukole H; Koenigsfeld M; Ramsey WJ; Vahanian N; Link CJ
J Immunother; 2008; 31(6):545-54. PubMed ID: 18528300
[TBL] [Abstract][Full Text] [Related]
5. Enrichment of xenograft-competent genetically modified pig cells using a targeted toxin, isolectin BS-I-B4 conjugate.
Akasaka E; Watanabe S; Himaki T; Ohtsuka M; Yoshida M; Miyoshi K; Sato M
Xenotransplantation; 2010; 17(1):81-9. PubMed ID: 20149191
[TBL] [Abstract][Full Text] [Related]
6. Glycoengineering of alphaGal xenoantigen on recombinant peptide bearing the J28 pancreatic oncofetal glycotope.
Sadoulet MO; Franceschi C; Aubert M; Silvy F; Bernard JP; Lombardo D; Mas E
Glycobiology; 2007 Jun; 17(6):620-30. PubMed ID: 17374617
[TBL] [Abstract][Full Text] [Related]
7. The αGal HyperAcute(®) Technology: enhancing immunogenicity of antiviral vaccines by exploiting the natural αGal-mediated zoonotic blockade.
Mandell RB; Flick R; Staplin WR; Kaniewski LD; Carzoli AK; Manuszak RP; Wang J; Rossi GR; Vahanian NN; Link CJ
Zoonoses Public Health; 2009 Aug; 56(6-7):391-406. PubMed ID: 19486321
[TBL] [Abstract][Full Text] [Related]
8. Mechanisms of Gal(alpha)1-3Gal(beta)1-4GlcNAc-R (alphaGal) expression on porcine valve endothelial cells.
Farivar RS; Filsoufi F; Adams DH
J Thorac Cardiovasc Surg; 2003 Feb; 125(2):306-14. PubMed ID: 12579099
[TBL] [Abstract][Full Text] [Related]
9. Evidence for Galalpha(1-3)Gal expression on primary porcine hepatocytes: implications for bioartificial liver systems.
van de Kerkhove MP; Germans MR; Deurholt T; Hoekstra R; Joziasse DH; van Wijk AC; van Gulik TM; Chamuleau RA; Roos A
J Hepatol; 2005 Apr; 42(4):541-7. PubMed ID: 15763340
[TBL] [Abstract][Full Text] [Related]
10. Characterization of natural human anti-non-gal antibodies and their effect on activation of porcine gal-deficient endothelial cells.
Saethre M; Baumann BC; Fung M; Seebach JD; Mollnes TE
Transplantation; 2007 Jul; 84(2):244-50. PubMed ID: 17667817
[TBL] [Abstract][Full Text] [Related]
11. In vivo targeting of vaccinating tumor cells to antigen-presenting cells by a gene therapy method with adenovirus containing the alpha1,3galactosyltransferase gene.
Deriy L; Ogawa H; Gao GP; Galili U
Cancer Gene Ther; 2005 Jun; 12(6):528-39. PubMed ID: 15818383
[TBL] [Abstract][Full Text] [Related]
12. Pig cells that lack the gene for alpha1-3 galactosyltransferase express low levels of the gal antigen.
Sharma A; Naziruddin B; Cui C; Martin MJ; Xu H; Wan H; Lei Y; Harrison C; Yin J; Okabe J; Mathews C; Stark A; Adams CS; Houtz J; Wiseman BS; Byrne GW; Logan JS
Transplantation; 2003 Feb; 75(4):430-6. PubMed ID: 12605105
[TBL] [Abstract][Full Text] [Related]
13. Characteristics of CD59 up-regulation induced in porcine endothelial cells by alphaGal ligation and its association with protection from complement.
Grubbs BC; Benson BA; Dalmasso AP
Xenotransplantation; 2003 Sep; 10(5):387-97. PubMed ID: 12950982
[TBL] [Abstract][Full Text] [Related]
14. Recognition of a carbohydrate xenoepitope by human NKRP1A (CD161).
Christiansen D; Mouhtouris E; Milland J; Zingoni A; Santoni A; Sandrin MS
Xenotransplantation; 2006 Sep; 13(5):440-6. PubMed ID: 16925668
[TBL] [Abstract][Full Text] [Related]
15. In vivo gene transfer of endo-beta-galactosidase C removes alphaGal antigen on erythrocytes and endothelial cells of the organs.
Miki Y; Maruyama S; Liu D; Kobayashi T; Sato F; Shimizu H; Kato S; Sato W; Morita Y; Yuzawa Y; Muramatsu T; Matsuo S
Xenotransplantation; 2004 Sep; 11(5):444-51. PubMed ID: 15303981
[TBL] [Abstract][Full Text] [Related]
16. Glycolipid studies in small intestine and pancreas of alpha1,3-galactosyltransferase knockout miniature swine: alpha1,3GALT-KO animals lack alphaGAL antigens and contain novel blood group H compounds.
Diswall M; Angström J; Schuurman HJ; Dor FJ; Rydberg L; Breimer ME
Transplant Proc; 2008 Mar; 40(2):543-6. PubMed ID: 18374124
[TBL] [Abstract][Full Text] [Related]
17. No evidence for αGal epitope transfer from media containing FCS onto human endothelial cells in culture.
Ramm R; Hartmann T; Tudorache I; Haverich A; Hilfiker A
Xenotransplantation; 2015; 22(5):345-55. PubMed ID: 26301779
[TBL] [Abstract][Full Text] [Related]
18. Investigation of red blood cells from alpha1,3-galactosyltransferase-knockout pigs for human blood transfusion.
Rouhani FJ; Dor FJ; Cooper DK
Transfusion; 2004 Jul; 44(7):1004-12. PubMed ID: 15225240
[TBL] [Abstract][Full Text] [Related]
19. The serum level of xenoantibodies, and hDAF or alphaGAL expression on pig cells, modulate in vitro the protection given by hDAF to primate complement-mediated damage.
Díaz TM; Mañez R; Moscoso I; López D; Santamarina I; Lopez E; Centeno A; Domenéch N
Transplant Proc; 2005; 37(1):510-1. PubMed ID: 15808692
[TBL] [Abstract][Full Text] [Related]
20. Production of alpha 1,3-galactosyltransferase gene-deficient pigs by somatic cell nuclear transfer: a novel selection method for gal alpha 1,3-Gal antigen-deficient cells.
Fujimura T; Takahagi Y; Shigehisa T; Nagashima H; Miyagawa S; Shirakura R; Murakami H
Mol Reprod Dev; 2008 Sep; 75(9):1372-8. PubMed ID: 18288673
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
